[1] |
SUN Zhao-gang.
Attention should be paid to the research and development of Mycobacterium tuberculosis antigen detection technology
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 120-124.
|
[2] |
WANG Shao-hua, ZHAO Guo-lian, WANG Pei, TAN Xiao-wen, CUI Xiao-li, KANG Lei, DANG Li-yun.
Analysis of inconsistency between genotypic and phenotypic results of Mycobacterium tuberculosis rifampicin susceptibility test
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 169-173.
|
[3] |
ZHOU Ting-ting, ZHENG Xiao-man, OUYANG Jing, LU Yan-qiu, CHEN Yao-kai.
Research progress on genes and mechanism of Mycobacterium tuberculosis resistance to pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 102-105.
|
[4] |
Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College , Chinese Center for Disease Control and Prevention , Union Medical Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences .
Expert consensus on the estimation of the national burden on latent tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 4-8.
|
[5] |
GAO Lei, ZHANG Hui, HU Mao-gui, XU Cheng-dong, XIA Yin-yin, LI Tao, CHEN Wei, HE Yi-jun, CAO Xue-fang, XIN He-nan, ZHANG Hao-ran, ZHAO Yan-lin, WANG Jin-feng, CHENG Shi-ming, JIN Qi, LIU Jian-jun.
Estimation of the national burden on latent tuberculosis infection based a multi-center epidemiological survey and the space statistics model
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 54-59.
|
[6] |
XU Yin-juan, ZHAO Guo-lian, CUI Xiao-li, WANG Pei, TAN Xiao-wen, YANG Shan-shan, WU Hao..
Evaluation of the effect of a new domestic improved Middlebrook liquid culture reagent on the culture of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 60-63.
|
[7] |
Chinese Antituberculosis Association.
Expert consensus on detection and preventive treatment of latent tuberculosis infection in high-risk population
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 874-878.
|
[8] |
ZHAO Xiu-juan, MO Jing-lian, SUN Tao, LIU Lin, ZHONG Ye-teng, PEI Hua, XIA Qian-feng.
Prevalence and correlated factors of drug-resistant pulmonary tuberculosis admitted to the designated medical institutions in Hainan Province from 2015 to 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 916-923.
|
[9] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, ZHOU Yin-fa, ZHANG Tian-lin, WEI Shu-zhen.
Analysis of the drug resistance surveillance results of Mycobacterium tuberculosis in Fujian Province from 2016 to 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 924-928.
|
[10] |
ZHOU Ying-yu, FU Lei, ZHANG Wei-yan, WANG Bin, CHEN Xi, LU Yu, CHEN Xiao-you.
Analysis and comparative study on the virulence of several drug-resistant Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 952-960.
|
[11] |
MA Ting-ting, REN Fei, MA Jin-bao, YANG Han.
Resistance of prothionamided and sodium aminosalicylate among isoniazid resistant pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 961-964.
|
[12] |
QI Xue-ting, LU Yu, CHEN Xiao-you.
Pharmacodynamic characteristics and interaction of new antituberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 965-969.
|
[13] |
CAO Qian-qian, ZHU Bing-dong, NIU Hong-xia.
Research progress on recombinant protein subunit vaccine of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 970-974.
|
[14] |
XIA Hui, ZHAO Yan-lin.
Inspiration of the WHO Updated on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 761-765.
|
[15] |
HU Yan-jie, GONG Shi-wei, REN Yi.
Establishment and evaluation of rapid detection of pyrazinamide resistance of Mycobacterium tuberculosis by probe enzyme digestion using Surveyor
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 813-816.
|